Andrea M. Barsevick, RN, DNSc, AOCN
Director, Nursing Research

Like many of the other departments at Fox Chase, the Nursing Department backs its high standards for patient care with research on better methods for helping, in particular the care and treatment of oncology issues. More

Jeff Boyd, PhD
Senior Vice President
Chief Scientific Officer

As Chief Scientific Officer, Boyd coordinates and charts the future course of research at Fox Chase. More

Angela R. Bradbury, MD
Director, Margaret Dyson Family Risk Assessment Program

Dr. Bradbury has clinical expertise in the areas of general oncology, breast oncology, clinical cancer genetics and clinical medical ethics. More

Jonathan Chernoff, MD, PhD
VP
Deputy Scientific Director
Stanley P. Reimann Chair
in Oncology Research

Dr. Chernoff brings a wealth of institutional experience, a broad range of scientific expertise, and strong leadership skills to support and advise Dr. Boyd in all aspects of operational and strategic decision making.  In recognition of his national reputation in molecular oncology and biochemistry, Dr. Chernoff also holds the Stanley P. Reimann Chair in Oncology. More

Harry S. Cooper, MD
Vice Chairman, Pathology
Director, Clinical Laboratories

Dr. Cooper is nationally recognized as an outstanding surgical pathologist with a particular interest in diseases of the gastrointestinal tract. More

Mary B. Daly, MD, PhD, FACP
Chair, Department of Clinical Genetics,
Timothy R. Talbot Jr. Chair in Cancer Research

One of Philadelphia Magazine's Top Doctors for 2008 and 2009 in Medical Oncology, Dr. Daly is Fox Chase's Chair of the Department of Clinical Genetics and the Timothy R. Talbot Jr. Chair in Cancer Research. More

Veda N. Giri, MD
Director,
Prostate Cancer Risk Assessment Program
Assistant Professor,
Cancer Prevention and Control,
Medical Oncology, and Clinical Genetics

In 2006, Veda N. Giri, MD, was appointed Director of the Fox Chase Cancer Center Prostate Cancer Risk Assessment Program (PRAP). More

Andrew K. Godwin, PhD
Director, Clinical Molecular Genetics Laboratory Director, Biosample Repository

Andrew K. Godwin, PhD, and his team of researchers study the hereditary and non-hereditary factors that influence one's risk of developing breast cancer and response to therapy. More

Stuart R. Lessin, MD
Director,
Dermatology-Cutaneous Oncology Program

Dr. Lessin has a special interest in developing new strategies for prevention of skin cancer. New drugs may provide nontoxic therapies for patients with precursor lesions who are at highest risk for developing cutaneous T-cell lymphoma. More

Suzanne M. Miller, PhD
Director, Behavioral Research and the Psychosocial and Behavioral Medicine Program

Suzanne M. Miller, PhD, is a Senior Member in the Division of Population Science at Fox Chase Cancer Center (FCCC), where she is the Director of the Psychosocial and Biobehavioral Medicine Program, Director of the NCI-funded Behavioral Research Core Facility, Director of the DoD-funded Behavioral Center of Excellence in Breast Cancer, and Director of the Intervention Development and Measurement Core of the NCI-funded Cancer Information Service Research Consortium. More

Eric A. Ross, PhD
Senior Director, Academic Informatics
Associate Member

The Population Studies Facility (PSF) supports research conducted by peer-review funded investigators at Fox Chase with a team of skilled information systems professionals. More